Fibrinogen Degradation Products

Fibrinogen Degradation Products

Thrombin converts soluble fibrinogen into insoluble fibrin, which when cross-linked becomes the fibrin clot as the last step in the coagulation cascade. Fibrinogen is an acute-phase reactant protein in that the concentration rises sharply in response to many different physiological stimuli such as tissue inflammation or injury. High fibrinogen levels are associated with atherosclerotic cardiovascular disease and with the occurrence of myocardial infarction and stroke.

Other conditions in which fibrinogen is elevated are cancers of the stomach, breast, or kidney, and inflammatory disorders like rheumatoid arthritis. Reduced fibrinogen levels are prevalent in liver disease, prostate cancer, lung disease, bone marrow lesions, malnourishment, and disseminated intravascular coagulation. Other conditions of deficient fibrinogen are congenital afibrinogenaemia, hypofibrinogenaemia, and dysfibrinogenaemia.

The Fortress Diagnostics Fibrinogen reagent is an in vitro diagnostic assay intended for quantitative determination of fibrinogen in plasma.

Methodology  Latex Assay
Storage 2°C - 8°C
Product Name Number Kit Size
Fibrinogen Degradation Products (FDP) COAG114A 60 Tests

Request a Quote

Please get in touch to see how we can help

Contact Us Quote

Our website use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy & Cookies Policy